Phase 2/3 Adaptive Study of VX-147 in Adults With APOL1-mediated Proteinuric Kidney Disease
Summary
- Eligibility
- for people ages 18-60 (full criteria)
- Location
- at UC Irvine UCLA UCSF
- Dates
- study startedcompletion around
- Principal Investigator
- by Anjay Rastogi, MD, PhD (ucla)

Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at University of California Health
- Anjay Rastogi, MD, PhD (ucla)
Professor of Clinical, Medicine. Authored (or co-authored) 90 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Vertex Pharmaceuticals Incorporated
- ID
- NCT05312879
- Phase
- Phase 3 Kidney Disease Research Study
- Study Type
- Interventional
- Participants
- Expecting 466 study participants
- Last Updated